Petrus Trust Company, Lta Atri Cure, Inc. Transaction History
Petrus Trust Company, Lta
- $984 Million
- Q1 2025
A detailed history of Petrus Trust Company, Lta transactions in Atri Cure, Inc. stock. As of the latest transaction made, Petrus Trust Company, Lta holds 7,560 shares of ATRC stock, worth $256,964. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,560
Previous 7,560
-0.0%
Holding current value
$256,964
Previous $231,000
5.19%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ATRC
# of Institutions
237Shares Held
52MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$160 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$157 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$125 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$102 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$82.8 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.58B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...